TermID	Term	Enrichment	logP	Genes in Term	Target Genes in Term	Fraction of Targets in Term	Total Target Genes	Total Genes	Entrez Gene IDs	Gene Symbols
WP206	Fatty Acid Omega Oxidation	4.85318450553313e-05	-9.9332903764087	15	5	0.032051282051282	156	5311	127,126,130,216,125	ADH4,ADH1C,ADH6,ALDH1A1,ADH1B
WP383	Striated Muscle Contraction	0.000739184285394842	-7.20996329679832	38	6	0.0384615384615385	156	5311	70,4632,7136,7140,10398,4634	ACTC1,MYL1,TNNI2,TNNT3,MYL9,MYL3
WP474	Endochondral Ossification	0.00274693316292971	-5.89727020309703	65	7	0.0448717948717949	156	5311	1028,5745,55553,4256,3549,5167,579	CDKN1C,PTH1R,SOX6,MGP,IHH,ENPP1,NKX3-2
WP688	Catalytic cycle of mammalian Flavin-containing MonoOxygenases (FMOs)	0.00808729038388156	-4.81746153802188	5	2	0.0128205128205128	156	5311	2326,2327	FMO1,FMO2
WP716	Vitamin A and Carotenoid Metabolism	0.00883738640661764	-4.72876410140724	44	5	0.032051282051282	156	5311	216,948,6017,29881,127	ALDH1A1,CD36,RLBP1,NPC1L1,ADH4
WP368	Mitochondrial LC-Fatty Acid Beta-Oxidation	0.0124882938925918	-4.38296356204594	17	3	0.0192307692307692	156	5311	55825,788,33	PECR,SLC25A20,ACADL
WP3413	NOTCH1 regulation of human endothelial cell calcification	0.0146682274530268	-4.22207152214207	18	3	0.0192307692307692	156	5311	3714,4256,55553	JAG2,MGP,SOX6
WP3925	Amino Acid metabolism	0.0169650574245575	-4.07659949586764	91	7	0.0448717948717949	156	5311	151742,216,127,5166,5105,3158,126	PPM1L,ALDH1A1,ADH4,PDK4,PCK1,HMGCS2,ADH1C
WP2406	Cardiac Progenitor Differentiation	0.0189254765737753	-3.96724629774186	53	5	0.032051282051282	156	5311	3815,70,4684,22943,9241	KIT,ACTC1,NCAM1,DKK1,NOG
WP1589	Folate-Alcohol and Cancer Pathway	0.0213677859223836	-3.84587082183269	8	2	0.0128205128205128	156	5311	216,10840	ALDH1A1,ALDH1L1
WP51	Regulation of Actin Cytoskeleton	0.0305041959955689	-3.48989103120595	149	9	0.0576923076923077	156	5311	4638,5295,2149,55740,2252,4634,4632,929,2147	MYLK,PIK3R1,F2R,ENAH,FGF7,MYL3,MYL1,CD14,F2
WP61	Notch Signaling Pathway	0.0346365459245388	-3.36284591375446	62	5	0.032051282051282	156	5311	2625,4137,3714,5295,2273	GATA3,MAPT,JAG2,PIK3R1,FHL1
WP2865	IL1 and megakaryocytes in obesity	0.0356171551694172	-3.33492787041292	25	3	0.0192307692307692	156	5311	2147,8991,2149	F2,SELENBP1,F2R
WP176	Folate Metabolism	0.0511946757980328	-2.97211974066351	69	5	0.032051282051282	156	5311	2878,338,4353,6648,2147	GPX3,APOB,MPO,SOD2,F2
WP2848	Differentiation Pathway	0.0513220225742785	-2.96963532897703	48	4	0.0256410256410256	156	5311	22943,9241,8200,3815	DKK1,NOG,GDF5,KIT
WP2881	Estrogen Receptor Pathway	0.0540881667688516	-2.91713984591106	13	2	0.0128205128205128	156	5311	5105,5166	PCK1,PDK4
WP2855	Dopaminergic Neurogenesis	0.0565760017940031	-2.87217038025735	30	3	0.0192307692307692	156	5311	2735,1028,216	GLI1,CDKN1C,ALDH1A1
WP408	Oxidative Stress	0.0613359115790126	-2.79138977431044	31	3	0.0192307692307692	156	5311	6648,2878,50507	SOD2,GPX3,NOX4
WP24	Peptide GPCRs	0.0654335889547743	-2.72671955978187	74	5	0.032051282051282	156	5311	886,4987,10396,2359,6755	CCKAR,OPRL1,ATP8A1,FPR3,SSTR5
WP1533	Vitamin B12 Metabolism	0.0691373410724268	-2.67166030238137	53	4	0.0256410256410256	156	5311	2147,6648,4353,338	F2,SOD2,MPO,APOB
WP47	Hedgehog Signaling Pathway	0.0786107247684509	-2.54324714141932	16	2	0.0128205128205128	156	5311	2735,3549	GLI1,IHH
WP236	Adipogenesis	0.0897444836837937	-2.4107887166359	131	7	0.0448717948717949	156	5311	1271,2625,2662,6424,5105,3399,5740	CNTFR,GATA3,GDF10,SFRP4,PCK1,ID3,PTGIS
WP3664	Regulation of Wnt/B-catenin Signaling by Small Molecule Compounds	0.0965219015636094	-2.33798533718015	18	2	0.0128205128205128	156	5311	8325,6424	FZD8,SFRP4
WP558	Complement and Coagulation Cascades	0.0987039124820546	-2.31563069318595	60	4	0.0256410256410256	156	5311	5624,2149,2147,730	PROC,F2R,F2,C7
WP15	Selenium Micronutrient Network	0.111681306437509	-2.1921059419929	87	5	0.032051282051282	156	5311	2878,4353,338,6648,2147	GPX3,MPO,APOB,SOD2,F2
WP1603	Nicotine Activity on Chromaffin Cells	0.11244634126766	-2.18527913763206	4	1	0.00641025641025641	156	5311	775	CACNA1C
WP2636	Common Pathways Underlying Drug Addiction	0.124620955895332	-2.08247850141456	42	3	0.0192307692307692	156	5311	2911,107,2891	GRM1,ADCY1,GRIA2
WP49	IL-2 Signaling Pathway	0.124620955895332	-2.08247850141456	42	3	0.0192307692307692	156	5311	5295,4137,1154	PIK3R1,MAPT,CISH
WP364	IL-6 signaling pathway	0.131238595517935	-2.03073827257759	43	3	0.0192307692307692	156	5311	7432,5295,2549	VIP,PIK3R1,GAB1
WP100	Glutathione metabolism	0.135229026151951	-2.00078544794297	22	2	0.0128205128205128	156	5311	2946,2878	GSTM2,GPX3
WP311	Synthesis and Degradation of Ketone Bodies	0.138536103989691	-1.97662430869959	5	1	0.00641025641025641	156	5311	3158	HMGCS2
WP35	G Protein Signaling Pathways	0.146266822104158	-1.92232277655039	95	5	0.032051282051282	156	5311	2788,107,5136,27115,8622	GNG7,ADCY1,PDE1A,PDE7B,PDE8B
WP702	Metapathway biotransformation	0.14840975265594	-1.90777823170244	177	8	0.0512820512820513	156	5311	51302,7881,2326,260293,2878,2327,66002,2946	CYP39A1,KCNAB1,FMO1,CYP4X1,GPX3,FMO2,CYP4F12,GSTM2
WP536	Calcium Regulation in the Cardiac Cell	0.154900189543911	-1.86497430790666	151	7	0.0448717948717949	156	5311	6546,845,2788,816,482,107,775	SLC8A1,CASQ2,GNG7,CAMK2B,ATP1B2,ADCY1,CACNA1C
WP334	GPCRs, Class B Secretin-like	0.155689009377437	-1.85989479108943	24	2	0.0128205128205128	156	5311	23284,5745	ADGRL3,PTH1R
WP3891	Benzene metabolism	0.163863727014324	-1.80872012941347	6	1	0.00641025641025641	156	5311	4353	MPO
WP3668	Hypothesized Pathways in Pathogenesis of Cardiovascular Disease	0.166130040176774	-1.79498442274441	25	2	0.0128205128205128	156	5311	1490,285	CCN2,ANGPT2
WP2572	Primary Focal Segmental Glomerulosclerosis FSGS	0.171867363485634	-1.76103224217741	74	4	0.0256410256410256	156	5311	22943,1028,816,51196	DKK1,CDKN1C,CAMK2B,PLCE1
WP1544	MicroRNAs in cardiomyocyte hypertrophy	0.179828506917089	-1.71575162158604	102	5	0.032051282051282	156	5311	1154,5330,5608,4638,5295	CISH,PLCB2,MAP2K6,MYLK,PIK3R1
WP2118	Arrhythmogenic Right Ventricular Cardiomyopathy	0.183578359412566	-1.69511367586602	76	4	0.0256410256410256	156	5311	6546,775,6445,6444	SLC8A1,CACNA1C,SGCG,SGCD
WP3845	Canonical  and Non-canonical Notch signaling	0.187350845611702	-1.67477224021272	27	2	0.0128205128205128	156	5311	3714,4237	JAG2,MFAP2
WP2596	Gastric acid production	0.188451334666284	-1.66891547695773	7	1	0.00641025641025641	156	5311	7432	VIP
WP422	MAPK Cascade	0.208921962865931	-1.56579448015887	29	2	0.0128205128205128	156	5311	7786,5608	MAP3K12,MAP2K6
WP2018	RANKL/RANK (Receptor activator of NFKB (ligand)) Signaling Pathway	0.218568599922035	-1.52065535526789	55	3	0.0192307692307692	156	5311	5608,54,5295	MAP2K6,ACP5,PIK3R1
WP455	GPCRs, Class A Rhodopsin-like	0.229332383732927	-1.47258287042492	259	10	0.0641025641025641	156	5311	56656,6755,2359,51554,2825,2857,27334,886,4987,2149	OR2S2,SSTR5,FPR3,ACKR4,GPR1,GPR34,P2RY10,CCKAR,OPRL1,F2R
WP2828	Bladder Cancer	0.24169637089894	-1.42007300628431	32	2	0.0128205128205128	156	5311	7057,5295	THBS1,PIK3R1
WP3893	Development and heterogeneity of the ILC family	0.24169637089894	-1.42007300628431	32	2	0.0128205128205128	156	5311	9760,2625	TOX,GATA3
WP2197	Endothelin Pathways	0.252683618878882	-1.37561709107033	33	2	0.0128205128205128	156	5311	4632,4638	MYL1,MYLK
WP3676	BDNF-TrkB Signaling	0.252683618878882	-1.37561709107033	33	2	0.0128205128205128	156	5311	107,2549	ADCY1,GAB1
WP304	Kit receptor signaling pathway	0.25794007580242	-1.35502798536976	60	3	0.0192307692307692	156	5311	4137,5295,3815	MAPT,PIK3R1,KIT
WP3601	Composition of Lipid Particles	0.257985844765478	-1.35485056081576	10	1	0.00641025641025641	156	5311	338	APOB
WP143	Fatty Acid Beta Oxidation	0.263683617315821	-1.33300531377268	34	2	0.0128205128205128	156	5311	33,788	ACADL,SLC25A20
WP299	Nuclear Receptors in Lipid Metabolism and Toxicity	0.274686205606083	-1.29212590335553	35	2	0.0128205128205128	156	5311	5244,225	ABCB4,ABCD2
WP244	Alpha 6 Beta 4 signaling pathway	0.274686205606083	-1.29212590335553	35	2	0.0128205128205128	156	5311	5295,2549	PIK3R1,GAB1
WP3624	Lung fibrosis	0.282015225288963	-1.26579421911506	63	3	0.0192307692307692	156	5311	1490,2252,26585	CCN2,FGF7,GREM1
WP43	Oxidation by Cytochrome P450	0.282015225288963	-1.26579421911506	63	3	0.0192307692307692	156	5311	51302,66002,260293	CYP39A1,CYP4F12,CYP4X1
WP500	Glycogen Metabolism	0.285681801661423	-1.25287666914406	36	2	0.0128205128205128	156	5311	8908,5260	GYG2,PHKG1
WP2007	Iron metabolism in placenta	0.301019829276361	-1.20057913840857	12	1	0.00641025641025641	156	5311	30061	SLC40A1
WP1425	Bone Morphogenic Protein (BMP) Signalling and Regulation	0.301019829276361	-1.20057913840857	12	1	0.00641025641025641	156	5311	9241	NOG
WP106	Alanine and aspartate metabolism	0.301019829276361	-1.20057913840857	12	1	0.00641025641025641	156	5311	2875	GPT
WP3849	MAPK  and NFkB Signalling Pathways Inhibited by Yersinia YopJ	0.301019829276361	-1.20057913840857	12	1	0.00641025641025641	156	5311	5608	MAP2K6
WP117	GPCRs, Other	0.30472343852195	-1.18835067267373	95	4	0.0256410256410256	156	5311	2911,23284,2149,4935	GRM1,ADGRL3,F2R,GPR143
WP2447	Amyotrophic lateral sclerosis (ALS)	0.307616433100183	-1.17890161917496	38	2	0.0128205128205128	156	5311	5630,5608	PRPH,MAP2K6
WP289	Myometrial Relaxation and Contraction Pathways	0.319317289529021	-1.14157003249992	158	6	0.0384615384615385	156	5311	816,107,70,6546,10268,2788	CAMK2B,ADCY1,ACTC1,SLC8A1,RAMP3,GNG7
WP3876	BMP2-WNT4-FOXO1 Pathway in Human Primary Endometrial Stromal Cell Differentiation	0.32159746781246	-1.1344546154258	13	1	0.00641025641025641	156	5311	22943	DKK1
WP3680	Association Between Physico-Chemical Features and Toxicity Associated Pathways	0.322518876129128	-1.13159361382621	68	3	0.0192307692307692	156	5311	4632,4638,8325	MYL1,MYLK,FZD8
WP23	B Cell Receptor Signaling Pathway	0.324830722991987	-1.12445108467544	98	4	0.0256410256410256	156	5311	974,5295,5608,2549	CD79B,PIK3R1,MAP2K6,GAB1
WP127	IL-5 Signaling Pathway	0.329421504192659	-1.11041718045304	40	2	0.0128205128205128	156	5311	4137,5295	MAPT,PIK3R1
WP481	Insulin Signaling	0.335057807344438	-1.09345220280657	161	6	0.0384615384615385	156	5311	115703,5295,5167,5608,2549,7786	ARHGAP33,PIK3R1,ENPP1,MAP2K6,GAB1,MAP3K12
WP3853	ERK Pathway in Huntington's Disease	0.341573080307055	-1.07419362489471	14	1	0.00641025641025641	156	5311	2911	GRM1
WP322	Osteoblast Signaling	0.341573080307055	-1.07419362489471	14	1	0.00641025641025641	156	5311	5745	PTH1R
WP3915	Angiopoietin Like Protein 8 Regulatory Pathway	0.346428669547129	-1.06007834143708	132	5	0.032051282051282	156	5311	7786,53919,5105,5295,5608	MAP3K12,SLCO1C1,PCK1,PIK3R1,MAP2K6
WP3	Transcriptional activation by NRF2	0.360964169510245	-1.01897657900943	15	1	0.00641025641025641	156	5311	4094	MAF
WP501	GPCRs, Class C Metabotropic glutamate, pheromone	0.37978773249432	-0.968142781035242	16	1	0.00641025641025641	156	5311	2911	GRM1
WP12	Osteoclast Signaling	0.37978773249432	-0.968142781035242	16	1	0.00641025641025641	156	5311	54	ACP5
WP53	ID signaling pathway	0.37978773249432	-0.968142781035242	16	1	0.00641025641025641	156	5311	3399	ID3
WP550	Biogenic Amine Synthesis	0.37978773249432	-0.968142781035242	16	1	0.00641025641025641	156	5311	5053	PAH
WP1946	Cori Cycle	0.37978773249432	-0.968142781035242	16	1	0.00641025641025641	156	5311	2875	GPT
WP2453	TCA Cycle and Deficiency of Pyruvate Dehydrogenase complex (PDHc)	0.37978773249432	-0.968142781035242	16	1	0.00641025641025641	156	5311	5105	PCK1
WP2291	Deregulation of Rab and Rab Effector Genes in Bladder Cancer	0.37978773249432	-0.968142781035242	16	1	0.00641025641025641	156	5311	54843	SYTL2
WP465	Tryptophan metabolism	0.393511742930496	-0.932644369306937	46	2	0.0128205128205128	156	5311	216,66002	ALDH1A1,CYP4F12
WP28	Selenium Metabolism and Selenoproteins	0.393511742930496	-0.932644369306937	46	2	0.0128205128205128	156	5311	2878,8991	GPX3,SELENBP1
WP3874	Canonical and Non-Canonical TGF-B signaling	0.398060275217286	-0.921151839894815	17	1	0.00641025641025641	156	5311	26585	GREM1
WP3879	4-hydroxytamoxifen, Dexamethasone, and Retinoic Acids Regulation of p27 Expression	0.415797826609629	-0.877556130580955	18	1	0.00641025641025641	156	5311	5608	MAP2K6
WP2380	Brain-Derived Neurotrophic Factor (BDNF) signaling pathway	0.417136835937993	-0.874340967274522	144	5	0.032051282051282	156	5311	4137,2891,4684,84894,5295	MAPT,GRIA2,NCAM1,LINGO1,PIK3R1
WP286	IL-3 Signaling Pathway	0.424538602011029	-0.85675234212121	49	2	0.0128205128205128	156	5311	5169,5295	ENPP3,PIK3R1
WP534	Glycolysis and Gluconeogenesis	0.424538602011029	-0.85675234212121	49	2	0.0128205128205128	156	5311	5224,5105	PGAM2,PCK1
WP1992	TarBasePathway	0.43301595225831	-0.836980710415058	19	1	0.00641025641025641	156	5311	2078	ERG
WP22	IL-9 Signaling Pathway	0.43301595225831	-0.836980710415058	19	1	0.00641025641025641	156	5311	5295	PIK3R1
WP697	Estrogen metabolism	0.43301595225831	-0.836980710415058	19	1	0.00641025641025641	156	5311	415	ARSE
WP2879	Farnesoid X Receptor  Pathway	0.43301595225831	-0.836980710415058	19	1	0.00641025641025641	156	5311	5244	ABCB4
WP2059	Alzheimers Disease	0.440534025032328	-0.819767594744796	148	5	0.032051282051282	156	5311	775,4137,5330,6622,2905	CACNA1C,MAPT,PLCB2,SNCA,GRIN2C
WP2261	Signaling Pathways in Glioblastoma	0.442713964293409	-0.814831396273244	83	3	0.0192307692307692	156	5311	5295,2549,5608	PIK3R1,GAB1,MAP2K6
WP3611	Photodynamic therapy-induced AP-1 survival signaling.	0.444766191218907	-0.810206547884889	51	2	0.0128205128205128	156	5311	5608,2252	MAP2K6,FGF7
WP497	Urea cycle and metabolism of amino groups	0.449729767718848	-0.79910839278017	20	1	0.00641025641025641	156	5311	2593	GAMT
WP516	Hypertrophy Model	0.449729767718848	-0.79910839278017	20	1	0.00641025641025641	156	5311	3491	CCN1
WP1602	Nicotine Activity on Dopaminergic Neurons	0.46595395147381	-0.763668466318977	21	1	0.00641025641025641	156	5311	84152	PPP1R1B
WP691	Tamoxifen metabolism	0.46595395147381	-0.763668466318977	21	1	0.00641025641025641	156	5311	2326	FMO1
WP3670	Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway	0.46595395147381	-0.763668466318977	21	1	0.00641025641025641	156	5311	2252	FGF7
WP2864	Apoptosis-related network due to altered Notch3 in ovarian cancer	0.474356449301177	-0.745796237154352	54	2	0.0128205128205128	156	5311	2149,7057	F2R,THBS1
WP545	Complement Activation	0.481702757445769	-0.730428040957594	22	1	0.00641025641025641	156	5311	730	C7
WP167	Eicosanoid Synthesis	0.481702757445769	-0.730428040957594	22	1	0.00641025641025641	156	5311	5740	PTGIS
WP1424	Globo Sphingolipid Metabolism	0.481702757445769	-0.730428040957594	22	1	0.00641025641025641	156	5311	256435	ST6GALNAC3
WP357	Fatty Acid Biosynthesis	0.481702757445769	-0.730428040957594	22	1	0.00641025641025641	156	5311	55825	PECR
WP272	Blood Clotting Cascade	0.481702757445769	-0.730428040957594	22	1	0.00641025641025641	156	5311	2147	F2
WP395	IL-4 Signaling Pathway	0.484008820976565	-0.72565214727339	55	2	0.0128205128205128	156	5311	5295,2625	PIK3R1,GATA3
WP585	Interferon type I signaling pathways	0.484008820976565	-0.72565214727339	55	2	0.0128205128205128	156	5311	5608,5295	MAP2K6,PIK3R1
WP2857	Mesodermal Commitment Pathway	0.486623882435088	-0.720263769617035	156	5	0.032051282051282	156	5311	9760,2625,22943,8325,9241	TOX,GATA3,DKK1,FZD8,NOG
WP195	IL-1 signaling pathway	0.502983720850607	-0.687197473520229	57	2	0.0128205128205128	156	5311	5295,5608	PIK3R1,MAP2K6
WP3658	Wnt/beta-catenin Signaling Pathway in Leukemia	0.511829201908286	-0.669764299619037	24	1	0.00641025641025641	156	5311	22943	DKK1
WP560	TGF-beta Receptor Signaling	0.512302584143938	-0.668839843849159	58	2	0.0128205128205128	156	5311	9241,7057	NOG,THBS1
WP306	Focal Adhesion	0.513694355321457	-0.666126829847547	195	6	0.0384615384615385	156	5311	7143,7057,80310,4638,5608,5295	TNR,THBS1,PDGFD,MYLK,MAP2K6,PIK3R1
WP2895	Differentiation of white and brown adipocyte	0.526233333639094	-0.64201056453153	25	1	0.00641025641025641	156	5311	1149	CIDEA
WP205	IL-7 Signaling Pathway	0.526233333639094	-0.64201056453153	25	1	0.00641025641025641	156	5311	5295	PIK3R1
WP3527	Preimplantation Embryo	0.530595458899	-0.633755395741431	60	2	0.0128205128205128	156	5311	360,2625	AQP3,GATA3
WP26	Signal Transduction of S1P Receptor	0.540215096786225	-0.61578789135321	26	1	0.00641025641025641	156	5311	5330	PLCB2
WP581	EPO Receptor Signaling	0.540215096786225	-0.61578789135321	26	1	0.00641025641025641	156	5311	1154	CISH
WP3584	MECP2 and Associated Rett Syndrome	0.548420418004857	-0.600713100030729	62	2	0.0128205128205128	156	5311	1749,2593	DLX5,GAMT
WP382	MAPK Signaling Pathway	0.563756823995951	-0.573132283589372	170	5	0.032051282051282	156	5311	4137,7786,4068,929,5608	MAPT,MAP3K12,SH2D1A,CD14,MAP2K6
WP2249	Metastatic brain tumor	0.566960390615157	-0.567465835516149	28	1	0.00641025641025641	156	5311	5295	PIK3R1
WP3594	Circadian rythm related genes	0.573038810362596	-0.556801832689202	207	6	0.0384615384615385	156	5311	1628,6097,4987,5593,107,3399	DBP,RORC,OPRL1,PRKG2,ADCY1,ID3
WP2583	T-Cell Receptor and Co-stimulatory Signaling	0.579747477316785	-0.545162654185356	29	1	0.00641025641025641	156	5311	5133	PDCD1
WP3613	Photodynamic therapy-induced unfolded protein response	0.579747477316785	-0.545162654185356	29	1	0.00641025641025641	156	5311	121506	ERP27
WP2374	Oncostatin M Signaling Pathway	0.582639330400172	-0.540186928324524	66	2	0.0128205128205128	156	5311	5295,3491	PIK3R1,CCN1
WP185	Integrin-mediated Cell Adhesion	0.588078992708734	-0.530893998765116	103	3	0.0192307692307692	156	5311	11131,827,5608	CAPN11,CAPN6,MAP2K6
WP75	Toll-like Receptor Signaling Pathway	0.588078992708734	-0.530893998765116	103	3	0.0192307692307692	156	5311	5608,929,5295	MAP2K6,CD14,PIK3R1
WP3844	PI3K-AKT-mTOR signaling pathway and therapeutic opportunities	0.592159327669726	-0.523979545731106	30	1	0.00641025641025641	156	5311	5295	PIK3R1
WP241	One Carbon Metabolism	0.592159327669726	-0.523979545731106	30	1	0.00641025641025641	156	5311	10840	ALDH1L1
WP98	Prostaglandin Synthesis and Regulation	0.592159327669726	-0.523979545731106	30	1	0.00641025641025641	156	5311	5740	PTGIS
WP2032	Human Thyroid Stimulating Hormone (TSH) signaling pathway	0.599025421000937	-0.512451242700526	68	2	0.0128205128205128	156	5311	5295,5608	PIK3R1,MAP2K6
WP3303	Rac1/Pak1/p38/MMP-2 pathway	0.599025421000937	-0.512451242700526	68	2	0.0128205128205128	156	5311	285,5295	ANGPT2,PIK3R1
WP428	Wnt Signaling Pathway	0.614927390041416	-0.486251083119145	70	2	0.0128205128205128	156	5311	8325,6424	FZD8,SFRP4
WP1449	Regulation of toll-like receptor signaling pathway	0.622008731595268	-0.474801148406974	145	4	0.0256410256410256	156	5311	5295,5608,929,1154	PIK3R1,MAP2K6,CD14,CISH
WP453	Inflammatory Response Pathway	0.627251307519038	-0.466408009211612	33	1	0.00641025641025641	156	5311	7057	THBS1
WP430	Statin Pathway	0.627251307519038	-0.466408009211612	33	1	0.00641025641025641	156	5311	338	APOB
WP313	Signaling of Hepatocyte Growth Factor Receptor	0.638268510258274	-0.448996221701334	34	1	0.00641025641025641	156	5311	2549	GAB1
WP1601	Fluoropyrimidine Activity	0.638268510258274	-0.448996221701334	34	1	0.00641025641025641	156	5311	2030	SLC29A1
WP400	p38 MAPK Signaling Pathway	0.638268510258274	-0.448996221701334	34	1	0.00641025641025641	156	5311	5608	MAP2K6
WP2034	Leptin signaling pathway	0.65974389180078	-0.415903561995818	76	2	0.0128205128205128	156	5311	5295,1154	PIK3R1,CISH
WP2037	Prolactin Signaling Pathway	0.65974389180078	-0.415903561995818	76	2	0.0128205128205128	156	5311	1154,5295	CISH,PIK3R1
WP3614	Photodynamic therapy-induced HIF-1 survival signaling	0.669415993854269	-0.401349597669502	37	1	0.00641025641025641	156	5311	285	ANGPT2
WP2526	PDGF Pathway	0.679194360369629	-0.386847947362186	38	1	0.00641025641025641	156	5311	5295	PIK3R1
WP170	Nuclear Receptors	0.68868529148134	-0.372970873590954	39	1	0.00641025641025641	156	5311	6097	RORC
WP524	G13 Signaling Pathway	0.697897183470952	-0.359683488687261	40	1	0.00641025641025641	156	5311	4632	MYL1
WP2911	miRNA targets in ECM and membrane receptors	0.723938973372445	-0.323048181071138	43	1	0.00641025641025641	156	5311	7057	THBS1
WP2332	Interleukin-11 Signaling Pathway	0.732113901267169	-0.311819174301688	44	1	0.00641025641025641	156	5311	5295	PIK3R1
WP268	Notch Signaling Pathway	0.747749064491728	-0.290687832570517	46	1	0.00641025641025641	156	5311	3714	JAG2
WP1971	Integrated Cancer Pathway	0.747749064491728	-0.290687832570517	46	1	0.00641025641025641	156	5311	10811	NOXA1
WP69	T-Cell antigen Receptor (TCR)  Signaling Pathway	0.753615700451108	-0.28287272200507	91	2	0.0128205128205128	156	5311	2625,5295	GATA3,PIK3R1
WP2203	Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway	0.755223166289952	-0.280741988919598	47	1	0.00641025641025641	156	5311	1154	CISH
WP366	TGF-beta Signaling Pathway	0.755919120574235	-0.279820891893147	133	3	0.0192307692307692	156	5311	7057,5608,5295	THBS1,MAP2K6,PIK3R1
WP2586	Aryl Hydrocarbon Receptor	0.762477190994355	-0.271182684398013	48	1	0.00641025641025641	156	5311	948	CD36
WP2849	Hematopoietic Stem Cell Differentiation	0.762477190994355	-0.271182684398013	48	1	0.00641025641025641	156	5311	4778	NFE2
WP1772	Apoptosis Modulation and Signaling	0.769488590312023	-0.262029153217909	94	2	0.0128205128205128	156	5311	79444,5414	BIRC7,SEPTIN4
WP2637	Structural Pathway of Interleukin 1 (IL-1)	0.776350580512462	-0.253151081809425	50	1	0.00641025641025641	156	5311	5608	MAP2K6
WP2884	NRF2 pathway	0.798055028702648	-0.225577725635846	143	3	0.0192307692307692	156	5311	2042,2878,2946	EPHA3,GPX3,GSTM2
WP673	ErbB Signaling Pathway	0.801727532480444	-0.220986463900443	54	1	0.00641025641025641	156	5311	2549	GAB1
WP3286	Copper homeostasis	0.801727532480444	-0.220986463900443	54	1	0.00641025641025641	156	5311	4137	MAPT
WP2853	Endoderm Differentiation	0.805718389103495	-0.216020990699367	145	3	0.0192307692307692	156	5311	9241,9760,22943	NOG,TOX,DKK1
WP2064	Neural Crest Differentiation	0.80755440705858	-0.213744848992736	102	2	0.0128205128205128	156	5311	1749,2670	DLX5,GFAP
WP2272	Pathogenic Escherichia coli infection	0.80761121232873	-0.213674509122334	55	1	0.00641025641025641	156	5311	929	CD14
WP2795	Cardiac Hypertrophic Response	0.81886312577396	-0.199838332692891	57	1	0.00641025641025641	156	5311	5608	MAP2K6
WP615	Senescence and Autophagy in Cancer	0.824420934541328	-0.193074036618513	106	2	0.0128205128205128	156	5311	7057,9547	THBS1,CXCL14
WP3863	T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection	0.84421330146321	-0.169350089464087	62	1	0.00641025641025641	156	5311	5133	PDCD1
WP710	DNA Damage Response (only ATM dependent)	0.854244903145413	-0.157537354471713	114	2	0.0128205128205128	156	5311	5295,6648	PIK3R1,SOD2
WP437	EGF/EGFR Signaling Pathway	0.861512822489141	-0.149065339214132	162	3	0.0192307692307692	156	5311	51196,2549,5295	PLCE1,GAB1,PIK3R1
WP706	Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways	0.861512822489141	-0.149065339214132	162	3	0.0192307692307692	156	5311	2625,3764,5053	GATA3,KCNJ8,PAH
WP1403	AMP-activated Protein Kinase (AMPK) Signaling	0.870020472869025	-0.13923853557702	68	1	0.00641025641025641	156	5311	5295	PIK3R1
WP45	G1 to S cell cycle control	0.870020472869025	-0.13923853557702	68	1	0.00641025641025641	156	5311	1028	CDKN1C
WP2431	Spinal Cord Injury	0.870476294626204	-0.138714752050255	119	2	0.0128205128205128	156	5311	2670,50507	GFAP,NOX4
WP2359	Parkin-Ubiquitin Proteasomal System pathway	0.877640928760393	-0.130517733961383	70	1	0.00641025641025641	156	5311	6622	SNCA
WP2328	Allograft Rejection	0.909574772656638	-0.0947780714767732	80	1	0.00641025641025641	156	5311	55825	PECR
WP2371	Parkinsons Disease Pathway	0.917427405556017	-0.0861818241935138	83	1	0.00641025641025641	156	5311	6622	SNCA
WP254	Apoptosis	0.924602098131858	-0.0783917981986403	86	1	0.00641025641025641	156	5311	5295	PIK3R1
WP2858	Ectoderm Differentiation	0.927673533792241	-0.075075403572983	143	2	0.0128205128205128	156	5311	8325,6622	FZD8,SNCA
WP138	Androgen receptor signaling pathway	0.933213621945269	-0.0691211419147482	90	1	0.00641025641025641	156	5311	5295	PIK3R1
WP2377	Integrated Pancreatic Cancer Pathway	0.934201261227414	-0.0680633808535824	197	3	0.0192307692307692	156	5311	10811,4137,7057	NOXA1,MAPT,THBS1
WP111	Electron Transport Chain	0.937145432553774	-0.0649167979511984	92	1	0.00641025641025641	156	5311	7351	UCP2
WP231	TNF alpha Signaling Pathway	0.940847168425177	-0.0609745665882143	94	1	0.00641025641025641	156	5311	5608	MAP2K6
WP179	Cell Cycle	0.957654747772632	-0.0432679545131484	105	1	0.00641025641025641	156	5311	219972	MPEG1
WP399	Wnt Signaling Pathway and Pluripotency	0.958923641230956	-0.041943830594189	106	1	0.00641025641025641	156	5311	8325	FZD8
WP1984	Integrated Breast Cancer Pathway	0.990530469821142	-0.00951465125595469	154	1	0.00641025641025641	156	5311	10811	NOXA1
WP229	Irinotecan Pathway	0.999999999984949	-1.50510808859783e-11	14	0	0	156	5311
WP2436	Dopamine metabolism	0.999999999984949	-1.50510808859783e-11	14	0	0	156	5311
WP2113	Type III interferon signaling	0.99999999998695	-1.30503034132478e-11	10	0	0	156	5311
WP2333	Trans-sulfuration pathway	0.99999999998695	-1.30503034132478e-11	10	0	0	156	5311
WP496	Steroid Biosynthesis	0.99999999998695	-1.30503034132478e-11	10	0	0	156	5311
WP3656	Interleukin-1 Induced Activation of NF-kappa-B	0.99999999998695	-1.30503034132478e-11	10	0	0	156	5311
WP1531	Vitamin D Metabolism	0.99999999998695	-1.30503034132478e-11	10	0	0	156	5311
WP704	Methylation Pathways	0.99999999998695	-1.30503034132478e-11	10	0	0	156	5311
WP2874	Liver X Receptor Pathway	0.99999999998695	-1.30503034132478e-11	10	0	0	156	5311
WP1	Statin Pathway	0.999999999989078	-1.09221694188921e-11	1	0	0	156	5311
WP661	Glucose Homeostasis	0.999999999989078	-1.09221694188921e-11	1	0	0	156	5311
WP2536	Colchicine Metabolic Pathway	0.999999999989078	-1.09221694188921e-11	1	0	0	156	5311
WP2190	One carbon donor	0.999999999989078	-1.09221694188921e-11	1	0	0	156	5311
WP108	Selenium metabolism/Selenoproteins	0.999999999989078	-1.09221694188921e-11	1	0	0	156	5311
WP3191	TSLP Signaling Pathway	0.999999999989078	-1.09221694188921e-11	1	0	0	156	5311
WP188	Focal Adhesion	0.999999999989078	-1.09221694188921e-11	1	0	0	156	5311
WP3627	Gut-Liver Indole Metabolism	0.999999999989078	-1.09221694188921e-11	1	0	0	156	5311
WP288	NLR Proteins	0.999999999989219	-1.07811298245624e-11	9	0	0	156	5311
WP3674	Tgif disruption of Shh signaling	0.999999999989219	-1.07811298245624e-11	9	0	0	156	5311
WP531	Mismatch repair	0.999999999989219	-1.07811298245624e-11	9	0	0	156	5311
WP3297	EV release from cardiac cells and their functional effects	0.999999999989219	-1.07811298245624e-11	9	0	0	156	5311
WP3875	ATR Signaling	0.999999999989219	-1.07811298245624e-11	9	0	0	156	5311
WP2942	DDX1 as a regulatory component of the Drosha microprocessor	0.999999999989219	-1.07811298245624e-11	9	0	0	156	5311
WP561	Heme Biosynthesis	0.999999999989219	-1.07811298245624e-11	9	0	0	156	5311
WP3593	miR-148a/miR-31/FIH1/HIF1&alpha;-Notch signaling in glioblastoma	0.999999999989219	-1.07811298245624e-11	9	0	0	156	5311
WP3585	Cytosine methylation	0.999999999989219	-1.07811298245624e-11	9	0	0	156	5311
WP3300	Dual hijack model of Vif in HIV infection	0.999999999989219	-1.07811298245624e-11	9	0	0	156	5311
WP696	Benzo(a)pyrene metabolism	0.999999999989219	-1.07811298245624e-11	9	0	0	156	5311
WP3596	miR-517 relationship with ARCN1 and USP1	0.99999999998941	-1.05895542592819e-11	5	0	0	156	5311
WP2597	Secretion of Hydrochloric Acid in Parietal Cells	0.99999999998941	-1.05895542592819e-11	5	0	0	156	5311
WP2542	Sulindac Metabolic Pathway	0.99999999998941	-1.05895542592819e-11	5	0	0	156	5311
WP2868	TCA Cycle Nutrient Utilization and Invasiveness of Ovarian Cancer	0.99999999998941	-1.05895542592819e-11	5	0	0	156	5311
WP1528	Physiological and Pathological Hypertrophy  of the Heart	0.999999999989543	-1.04571926469288e-11	25	0	0	156	5311
WP1600	Nicotine Metabolism	0.999999999991183	-8.81678560044857e-12	6	0	0	156	5311
WP694	Arylamine metabolism	0.999999999991183	-8.81678560044857e-12	6	0	0	156	5311
WP1981	Thyroxine (Thyroid Hormone) Production	0.999999999991183	-8.81678560044857e-12	6	0	0	156	5311
WP3633	Caffeine and Theobromine metabolism	0.999999999991386	-8.61381424124064e-12	4	0	0	156	5311
WP1941	Peroxisomal beta-oxidation of tetracosanoyl-CoA	0.999999999991386	-8.61381424124064e-12	4	0	0	156	5311
WP897	Androgen receptor signaling pathway	0.999999999991386	-8.61381424124064e-12	4	0	0	156	5311
WP521	Amino acid conjugation of benzoic acid	0.999999999991386	-8.61381424124064e-12	4	0	0	156	5311
WP733	Serotonin Receptor 2 and STAT3 Signaling	0.999999999991386	-8.61381424124064e-12	4	0	0	156	5311
WP690	Polyol Pathway	0.999999999991386	-8.61381424124064e-12	4	0	0	156	5311
WP2253	Pilocytic astrocytoma	0.999999999991386	-8.61381424124064e-12	4	0	0	156	5311
WP2491	Diclofenac Metabolic Pathway	0.999999999991386	-8.61381424124064e-12	4	0	0	156	5311
WP1133	Androgen receptor signaling pathway	0.999999999991386	-8.61381424124064e-12	4	0	0	156	5311
WP3302	eIF5A regulation in response to inhibition of the nuclear export system	0.999999999991386	-8.61381424124064e-12	4	0	0	156	5311
WP2889	Oxytocin signaling	0.999999999991386	-8.61381424124064e-12	4	0	0	156	5311
WP3529	Zinc homeostasis	0.999999999993246	-6.75452900736519e-12	37	0	0	156	5311
WP3414	Initiation of transcription and translation elongation at the HIV-1 LTR	0.999999999993246	-6.75452900736519e-12	37	0	0	156	5311
WP1471	Target Of Rapamycin (TOR) Signaling	0.999999999993246	-6.75452900736519e-12	37	0	0	156	5311
WP619	Type II interferon signaling (IFNG)	0.999999999993246	-6.75452900736519e-12	37	0	0	156	5311
WP2507	Nanomaterial induced apoptosis	0.999999999993335	-6.66484890172255e-12	21	0	0	156	5311
WP2533	Glycerophospholipid Biosynthetic Pathway	0.999999999993335	-6.66484890172255e-12	21	0	0	156	5311
WP1422	Sphingolipid Metabolism	0.999999999993521	-6.47875548289191e-12	20	0	0	156	5311
WP391	Mitochondrial Gene Expression	0.999999999993521	-6.47875548289191e-12	20	0	0	156	5311
WP732	Serotonin Receptor 2 and ELK-SRF/GATA4 signaling	0.999999999993521	-6.47875548289191e-12	20	0	0	156	5311
WP1742	TP53 Network	0.999999999993521	-6.47875548289191e-12	20	0	0	156	5311
WP1434	Osteopontin Signaling	0.999999999994012	-5.98812297220803e-12	13	0	0	156	5311
WP1991	SRF and miRs in Smooth Muscle Differentiation and Proliferation	0.999999999994012	-5.98812297220803e-12	13	0	0	156	5311
WP3892	Development of pulmonary dendritic cells and macrophage subsets	0.999999999994012	-5.98812297220803e-12	13	0	0	156	5311
WP186	Homologous recombination	0.999999999994012	-5.98812297220803e-12	13	0	0	156	5311
WP1423	Ganglio Sphingolipid Metabolism	0.999999999994012	-5.98812297220803e-12	13	0	0	156	5311
WP3871	Valproic acid pathway	0.999999999994012	-5.98812297220803e-12	13	0	0	156	5311
WP3679	Cell-type Dependent Selectivity of CCK2R Signaling	0.999999999994012	-5.98812297220803e-12	13	0	0	156	5311
WP2846	Proprotein convertase subtilisin/kexin type 9 (PCSK9) mediated LDL receptor degradation	0.999999999995044	-4.9563810561727e-12	3	0	0	156	5311
WP3408	Evolocumab Mechanism	0.999999999995044	-4.9563810561727e-12	3	0	0	156	5311
WP3612	Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling	0.999999999995885	-4.11467470729903e-12	23	0	0	156	5311
WP712	Estrogen signaling pathway	0.999999999995885	-4.11467470729903e-12	23	0	0	156	5311
WP2035	Follicle Stimulating Hormone (FSH) signaling pathway	0.999999999995902	-4.09786617468332e-12	27	0	0	156	5311
WP2361	Gastric Cancer Network 1	0.999999999996113	-3.88735129093322e-12	28	0	0	156	5311
WP2643	Nanoparticle-mediated activation of receptor signaling	0.999999999996489	-3.5106698301813e-12	29	0	0	156	5311
WP2943	Hypoxia-mediated EMT and Stemness	0.999999999996689	-3.31134035122527e-12	2	0	0	156	5311
WP2366	Butyrate-induced histone acetylation	0.999999999996689	-3.31134035122527e-12	2	0	0	156	5311
WP2646	Lidocaine metabolism	0.999999999996689	-3.31134035122527e-12	2	0	0	156	5311
WP2866	mir34a and TGIF2 in osteoclastogenesis	0.999999999996689	-3.31134035122527e-12	2	0	0	156	5311
WP2816	Felbamate Metabolism	0.999999999996689	-3.31134035122527e-12	2	0	0	156	5311
WP1311	Folic Acid Network	0.999999999996689	-3.31134035122527e-12	2	0	0	156	5311
WP1273	Folic Acid Network	0.999999999996689	-3.31134035122527e-12	2	0	0	156	5311
WP2901	Gonadotropin-releasing hormone (GnRH) signaling	0.999999999996689	-3.31134035122527e-12	2	0	0	156	5311
WP1438	Influenza A virus infection	0.999999999996689	-3.31134035122527e-12	2	0	0	156	5311
WP1995	Effects of Nitric Oxide	0.999999999997198	-2.80190135699954e-12	7	0	0	156	5311
WP2805	RNA interference	0.999999999997198	-2.80190135699954e-12	7	0	0	156	5311
WP678	Arachidonate Epoxygenase / Epoxide Hydrolase	0.999999999997198	-2.80190135699954e-12	7	0	0	156	5311
WP3595	mir-124 predicted interactions with cell cycle and differentiation	0.999999999997198	-2.80190135699954e-12	7	0	0	156	5311
WP528	Acetylcholine Synthesis	0.999999999997198	-2.80190135699954e-12	7	0	0	156	5311
WP1310	Selenium Micronutrient Network	0.999999999997198	-2.80190135699954e-12	7	0	0	156	5311
WP134	Pentose Phosphate Pathway	0.999999999997198	-2.80190135699954e-12	7	0	0	156	5311
WP3924	Hfe effect on hepcidin production	0.999999999997198	-2.80190135699954e-12	7	0	0	156	5311
WP438	Non-homologous end joining	0.999999999997198	-2.80190135699954e-12	7	0	0	156	5311
WP1272	Selenium Micronutrient Network	0.999999999997198	-2.80190135699954e-12	7	0	0	156	5311
WP699	Aflatoxin B1 metabolism	0.999999999997198	-2.80190135699954e-12	7	0	0	156	5311
WP3878	ATM Signaling Network in Development and Disease	0.999999999998596	-1.40412691018209e-12	46	0	0	156	5311
WP1591	Heart Development	0.999999999998596	-1.40412691018209e-12	46	0	0	156	5311
WP262	EBV LMP1 signaling	0.999999999998743	-1.257292468917e-12	24	0	0	156	5311
WP1539	Angiogenesis	0.999999999998743	-1.257292468917e-12	24	0	0	156	5311
WP2509	Nanoparticle triggered autophagic cell death	0.999999999998743	-1.257292468917e-12	24	0	0	156	5311
WP2854	Gene regulatory network modelling somitogenesis	0.999999999999282	-7.18465082604859e-13	11	0	0	156	5311
WP80	Nucleotide GPCRs	0.999999999999282	-7.18465082604859e-13	11	0	0	156	5311
WP1455	Serotonin Transporter Activity	0.999999999999282	-7.18465082604859e-13	11	0	0	156	5311
WP3630	NAD metabolism, sirtuins and aging	0.999999999999282	-7.18465082604859e-13	11	0	0	156	5311
WP2513	Nanoparticle triggered regulated necrosis	0.999999999999282	-7.18465082604859e-13	11	0	0	156	5311
WP3634	Insulin signalling in human adipocytes (normal condition)	1.00000000000013	1.26633324358418e-13	8	0	0	156	5311
WP2338	miRNA Biogenesis	1.00000000000013	1.26633324358418e-13	8	0	0	156	5311
WP237	Glucocorticoid &amp; Mineralcorticoid Metabolism	1.00000000000013	1.26633324358418e-13	8	0	0	156	5311
WP1604	Codeine and Morphine Metabolism	1.00000000000013	1.26633324358418e-13	8	0	0	156	5311
WP2276	Glial Cell Differentiation	1.00000000000013	1.26633324358418e-13	8	0	0	156	5311
WP136	Phase I biotransformations, non P450	1.00000000000013	1.26633324358418e-13	8	0	0	156	5311
WP3407	FTO Obesity Variant Mechanism	1.00000000000013	1.26633324358418e-13	8	0	0	156	5311
WP3635	Insulin signalling in human adipocytes (diabetic condition)	1.00000000000013	1.26633324358418e-13	8	0	0	156	5311
WP2485	NAD Biosynthesis II (from tryptophan)	1.00000000000013	1.26633324358418e-13	8	0	0	156	5311
WP3655	Hypothetical Craniofacial Development Pathway	1.00000000000013	1.26633324358418e-13	8	0	0	156	5311
WP78	TCA Cycle	1.00000000000033	3.2550455063239e-13	17	0	0	156	5311
WP554	ACE Inhibitor Pathway	1.00000000000033	3.2550455063239e-13	17	0	0	156	5311
WP2916	Interactome of polycomb repressive complex 2 (PRC2)	1.00000000000033	3.2550455063239e-13	17	0	0	156	5311
WP3678	Amplification and Expansion of Oncogenic Pathways as Metastatic Traits	1.00000000000033	3.2550455063239e-13	17	0	0	156	5311
WP2289	Drug Induction of Bile Acid Pathway	1.00000000000033	3.2550455063239e-13	17	0	0	156	5311
WP3872	Regulation of Apoptosis by Parathyroid Hormone-related Protein	1.00000000000034	3.42085777775067e-13	22	0	0	156	5311
WP3599	Transcription factor regulation in adipogenesis	1.00000000000034	3.42085777775067e-13	22	0	0	156	5311
WP3657	Hematopoietic Stem Cell Gene Regulation by GABP alpha/beta Complex	1.00000000000034	3.42085777775067e-13	22	0	0	156	5311
WP3645	NAD+ biosynthetic pathways	1.00000000000034	3.42085777775067e-13	22	0	0	156	5311
WP1584	Type II diabetes mellitus	1.00000000000034	3.42085777775067e-13	22	0	0	156	5311
WP314	Fas Ligand (FasL) pathway and Stress induction of Heat Shock Proteins (HSP) regulation	1.00000000000062	6.21582730299128e-13	44	0	0	156	5311
WP623	Oxidative phosphorylation	1.00000000000121	1.20905457245225e-12	54	0	0	156	5311
WP2875	Constitutive Androstane Receptor Pathway	1.00000000000125	1.24615544494597e-12	32	0	0	156	5311
WP2525	Trans-sulfuration and one carbon metabolism	1.00000000000125	1.24615544494597e-12	32	0	0	156	5311
WP34	Ovarian Infertility Genes	1.00000000000125	1.24615544494597e-12	32	0	0	156	5311
WP3858	Toll-like Receptor Signaling	1.00000000000125	1.24615544494597e-12	32	0	0	156	5311
WP727	Monoamine Transport	1.00000000000125	1.24615544494597e-12	32	0	0	156	5311
WP3644	NAD+ metabolism	1.00000000000137	1.37077190655272e-12	16	0	0	156	5311
WP2878	PPAR Alpha Pathway	1.00000000000156	1.55794298159246e-12	26	0	0	156	5311
WP325	Triacylglyceride Synthesis	1.00000000000156	1.55794298159246e-12	26	0	0	156	5311
WP530	Cytokines and Inflammatory Response	1.00000000000156	1.55794298159246e-12	26	0	0	156	5311
WP698	Glucuronidation	1.00000000000156	1.55794298159246e-12	26	0	0	156	5311
WP2873	Aryl Hydrocarbon Receptor Pathway	1.00000000000168	1.68318017535383e-12	48	0	0	156	5311
WP3617	Photodynamic therapy-induced NF-kB survival signaling	1.00000000000298	2.98252588906831e-12	35	0	0	156	5311
WP197	Cholesterol Biosynthesis	1.00000000000311	3.10684492345027e-12	15	0	0	156	5311
WP2435	Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis	1.00000000000311	3.10684492345027e-12	15	0	0	156	5311
WP692	Sulfation Biotransformation Reaction	1.00000000000314	3.13728132987526e-12	18	0	0	156	5311
WP3859	TGF-B Signaling in Thyroid Cells for Epithelial-Mesenchymal Transition	1.00000000000314	3.13728132987526e-12	18	0	0	156	5311
WP3851	TLR4 Signaling and Tolerance	1.00000000000318	3.17850836810589e-12	30	0	0	156	5311
WP2870	Extracellular vesicle-mediated signaling in recipient cells	1.00000000000318	3.17850836810589e-12	30	0	0	156	5311
WP129	Matrix Metalloproteinases	1.00000000000318	3.17850836810589e-12	30	0	0	156	5311
WP3850	Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling	1.00000000000332	3.32461775837966e-12	31	0	0	156	5311
WP2112	IL17 signaling pathway	1.00000000000332	3.32461775837966e-12	31	0	0	156	5311
WP2363	Gastric Cancer Network 2	1.00000000000342	3.41844913533106e-12	33	0	0	156	5311
WP58	Monoamine GPCRs	1.00000000000342	3.41844913533106e-12	33	0	0	156	5311
WP107	Translation Factors	1.00000000000372	3.71791677218882e-12	53	0	0	156	5311
WP363	Wnt Signaling Pathway Netpath	1.00000000000372	3.71791677218882e-12	53	0	0	156	5311
WP3651	Pathways Affected in Adenoid Cystic Carcinoma	1.00000000000386	3.8580317945765e-12	66	0	0	156	5311
WP183	Proteasome Degradation	1.00000000000386	3.8580317945765e-12	66	0	0	156	5311
WP2324	AGE/RAGE pathway	1.00000000000386	3.8580317945765e-12	66	0	0	156	5311
WP1982	Sterol Regulatory Element-Binding Proteins (SREBP) signalling	1.00000000000427	4.26957750234225e-12	73	0	0	156	5311
WP2011	SREBF and miR33 in cholesterol and lipid homeostasis	1.00000000000432	4.31799619809842e-12	19	0	0	156	5311
WP404	Nucleotide Metabolism	1.00000000000432	4.31799619809842e-12	19	0	0	156	5311
WP734	Serotonin Receptor 4/6/7 and NR3C Signaling	1.00000000000432	4.31799619809842e-12	19	0	0	156	5311
WP3287	Overview of nanoparticle effects	1.00000000000432	4.31799619809842e-12	19	0	0	156	5311
WP247	Small Ligand GPCRs	1.00000000000432	4.31799619809842e-12	19	0	0	156	5311
WP3877	Simplified Depiction of MYD88 Distinct Input-Output Pathway	1.00000000000432	4.31799619809842e-12	19	0	0	156	5311
WP384	Apoptosis Modulation by HSP70	1.00000000000432	4.31799619809842e-12	19	0	0	156	5311
WP405	Eukaryotic Transcription Initiation	1.00000000000448	4.48092887770545e-12	42	0	0	156	5311
WP2036	TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway	1.00000000000448	4.48092887770545e-12	42	0	0	156	5311
WP466	DNA Replication	1.00000000000448	4.48092887770545e-12	42	0	0	156	5311
WP2267	Synaptic Vesicle Pathway	1.00000000000506	5.06268202886498e-12	52	0	0	156	5311
WP1433	Nucleotide-binding Oligomerization Domain (NOD) pathway	1.00000000000537	5.36592902895203e-12	41	0	0	156	5311
WP3298	Melatonin metabolism and effects	1.00000000000548	5.47730837770307e-12	36	0	0	156	5311
WP2012	miRs in Muscle Cell Differentiation	1.00000000000548	5.47730837770307e-12	36	0	0	156	5311
WP3646	Hepatitis C and Hepatocellular Carcinoma	1.000000000006	5.9984929606417e-12	51	0	0	156	5311
WP3865	RIG-I-like Receptor Signaling	1.00000000000643	6.43190662531404e-12	61	0	0	156	5311
WP2516	ATM Signaling Pathway	1.00000000000675	6.74556823501691e-12	40	0	0	156	5311
WP2029	Cell Differentiation - Index	1.00000000000684	6.84279919945059e-12	38	0	0	156	5311
WP3301	MFAP5-mediated ovarian cancer cell motility and invasiveness	1.00000000000774	7.74474672060799e-12	12	0	0	156	5311
WP1559	TFs Regulate miRNAs related to cardiac hypertrophy	1.00000000000774	7.74474672060799e-12	12	0	0	156	5311
WP2290	RalA downstream regulated genes	1.00000000000774	7.74474672060799e-12	12	0	0	156	5311
WP3672	LncRNA-mediated mechanisms of therapeutic resistance	1.00000000000774	7.74474672060799e-12	12	0	0	156	5311
WP1545	miRNAs involved in DNA damage response	1.0000000000083	8.29506111616434e-12	50	0	0	156	5311
WP410	Diurnally Regulated Genes with Circadian Orthologs	1.0000000000087	8.6977433403548e-12	49	0	0	156	5311
WP2355	Corticotropin-releasing hormone signaling pathway	1.00000000001154	1.15376931076109e-11	93	0	0	156	5311
WP1530	miRNA Regulation of DNA Damage Response	1.00000000001154	1.15376931076109e-11	93	0	0	156	5311
WP2369	Histone Modifications	1.00000000001282	1.28194537633904e-11	69	0	0	156	5311
WP707	DNA Damage Response	1.00000000001282	1.28194537633904e-11	69	0	0	156	5311
WP411	mRNA Processing	1.00000000001384	1.38398918493227e-11	132	0	0	156	5311
WP477	Cytoplasmic Ribosomal Proteins	1.00000000001468	1.46791485264423e-11	90	0	0	156	5311
WP2446	Retinoblastoma (RB) in Cancer	1.00000000002313	2.31301366154752e-11	88	0	0	156	5311
